US Patent Issued to NACUITY PHARMACEUTICALS on Nov. 4 for "N-Acetylcysteine Amide (NACA) and (2R,2R')-3,3' disulfanediyl BIS(2-acetamidopropanamide) (DINACA) for the prevention and treatment of radiation dermatitis and skin lightening, skin whitening and skin improvement" (Texas Inventor)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,608, issued on Nov. 4, was assigned to NACUITY PHARMACEUTICALS INC. (Fort Worth, Texas).

"N-Acetylcysteine Amide (NACA) and (2R,2R')-3,3' disulfanediyl BIS(2-acetamidopropanamide) (DINACA) for the prevention and treatment of radiation dermatitis and skin lightening, skin whitening and skin improvement" was invented by G. Michael Wall (Fort Worth, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes a method for the use of N-acetylcysteine (NAC), N-acetylcysteine amide (NAC A) or (2R,2R')-3,3'-disulfanediylbis(2-acetamidopropanamide) (diNACA) for the prevention and treatment of radiation dermatitis, radiation damage to t...